Singson, Giselle L.
HRN: 22-50-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
01/26/2023
02/01/2023
IVT
750mg
Q8
UTI
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines